FGFR2 alteration as a potential therapeutic target in poorly cohesive gastric carcinoma.
Yue WangTao ShiXuan WangJinwei HuLixia YuQin LiuNandie WuBaorui LiuJia WeiPublished in: Journal of translational medicine (2021)
FGFR2 alterations were recurrent in PC GC and FGFR2 inhibitors might be a new therapeutic target for PC GC.